InspireMD Profit Margin 2013-2018 | NSPR
Current and historical gross margin, operating margin and net profit margin for InspireMD (NSPR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. InspireMD net profit margin as of December 31, 2018 is -201.05%.
|InspireMD Annual Profit Margins
|InspireMD Quarterly Profit Margins
||Medical Instruments Manufacturing
InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.